---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000627"
form_type: "8-K"
ticker: "ACON"
cik: "0001635077"
company_name: "Aclarion, Inc."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T04:42:52.893243+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aclarion prices $4.7M registered direct offering of 506,803 shares at $9.25 each

## Summary
- Gross proceeds ~$4.7M; 506,803 shares at $9.25/share; closing expected Jan 31, 2025.
- Net proceeds to fund market development, clinical evidence, product development, and G&A.
- Dawson James Securities serving as sole placement agent; offering under effective S-3 shelf.
- Offering priced at the market; no change to previously announced business plans.

## SEC filing metadata
- accession: 0001683168-25-000627
- form_type: 8-K
- ticker: ACON
- cik: 0001635077
- company_name: Aclarion, Inc.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635077/000168316825000627/0001683168-25-000627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635077/000168316825000627/acon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000627
- JSON: https://secwatch.observer/filing/0001683168-25-000627.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000627.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.